Pfizer Inc. (PFE)
NYSE: PFE · IEX Real-Time Price · USD
27.83
-0.39 (-1.38%)
At close: Jul 2, 2024, 4:01 PM
27.86
+0.03 (0.11%)
After-hours: Jul 2, 2024, 7:59 PM EDT
Pfizer Revenue
Pfizer had revenue of $55.09B in the twelve months ending March 31, 2024, down -40.86% year-over-year. Revenue in the quarter ending March 31, 2024 was $14.88B, a -19.51% decrease year-over-year. In the year 2023, Pfizer had annual revenue of $58.50B, a decrease of -41.70%.
Revenue (ttm)
$55.09B
Revenue Growth
-40.86%
P/S Ratio
2.86
Revenue / Employee
$626,068
Employees
88,000
Market Cap
157.70B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 58.50B | -41.83B | -41.70% |
Dec 31, 2022 | 100.33B | 19.04B | 23.43% |
Dec 31, 2021 | 81.29B | 39.64B | 95.16% |
Dec 31, 2020 | 41.65B | 746.00M | 1.82% |
Dec 31, 2019 | 40.91B | 80.00M | 0.20% |
Dec 31, 2018 | 40.83B | -11.72B | -22.31% |
Dec 31, 2017 | 52.55B | -278.00M | -0.53% |
Dec 31, 2016 | 52.82B | 3.97B | 8.13% |
Dec 31, 2015 | 48.85B | -754.00M | -1.52% |
Dec 31, 2014 | 49.61B | -1.98B | -3.84% |
Dec 31, 2013 | 51.58B | -3.07B | -5.62% |
Dec 31, 2012 | 54.66B | -6.38B | -10.45% |
Dec 31, 2011 | 61.04B | -4.13B | -6.34% |
Dec 31, 2010 | 65.17B | 15.90B | 32.26% |
Dec 31, 2009 | 49.27B | 973.00M | 2.01% |
Dec 31, 2008 | 48.30B | -122.00M | -0.25% |
Dec 31, 2007 | 48.42B | 47.00M | 0.10% |
Dec 31, 2006 | 48.37B | 966.00M | 2.04% |
Dec 31, 2005 | 47.41B | -1.58B | -3.23% |
Dec 31, 2004 | 48.99B | 4.25B | 9.50% |
Dec 31, 2003 | 44.74B | 12.44B | 38.53% |
Dec 31, 2002 | 32.29B | 3.27B | 11.27% |
Dec 31, 2001 | 29.02B | 2.98B | 11.44% |
Dec 31, 2000 | 26.05B | -1.12B | -4.13% |
Dec 31, 1999 | 27.17B | 3.94B | 16.94% |
Dec 31, 1998 | 23.23B | 12.18B | 110.14% |
Dec 31, 1997 | 11.06B | 1.19B | 12.07% |
Dec 31, 1996 | 9.86B | -157.00M | -1.57% |
Dec 31, 1995 | 10.02B | 2.04B | 25.62% |
Dec 31, 1994 | 7.98B | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Elevance Health | 171.75B |
Sanofi | 51.60B |
Novartis AG | 49.92B |
Thermo Fisher | 42.49B |
Abbott Laboratories | 40.33B |
Amgen | 29.53B |
Danaher | 22.52B |
Stryker | 20.96B |
PFE News
- 18 hours ago - UK court gives mixed ruling in Pfizer v Moderna COVID vaccine patents case - Reuters
- 1 day ago - Pfizer And Moderna Vaccines Not Linked To Birth Defects, Study Finds - Forbes
- 1 day ago - Cyrus Taraporevala Elected to Pfizer's Board of Directors - Business Wire
- 4 days ago - Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline - CNBC
- 5 days ago - Daily Dividend Report: AT&T, Kroger, Matson, Pfizer, Edison - Forbes
- 5 days ago - Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the European Union - Business Wire
- 6 days ago - Pfizer Declares Third-Quarter 2024 Dividend - Business Wire
- 6 days ago - Vaccine makers' stocks fall as CDC advisers shift RSV-shot recommendations - Market Watch